Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Vestas secures 42 MW order in France

News release from Vestas MediterraneanMadrid, 30 June 2020 The international renewable energy developer Valeco has placed a 42 MW order for three wind projects in France. The contract includes the supply and installation of eight V100-2.0 MW wind turbines delivered in 2.2 MW Power Optimised Mode and eight V117-3.45 MW wind turbines in 3.0 MW operating mode, as well as Active Output Management 5000 (AOM 5000) service agreements, designed to maximise energy production for the sites.  The name and location of the projects are undisclosed. Turbine delivery and commissioning are

Update from Omnicar Holding AB

Omnicar Holding AB is now ready to announce a new and exciting line of businessAs previously announced, we will provide guidance for 2020. Our quarterly numbers in 2020 will not deviate much from our Q1 2020 report. We do not expect an negative deviation on revenue and profit in 2020 as long as Covid-19 remains under control  However, we will here announce how we will grow the company in 2020 and going forward We have previously announced our initiative regarding omnicarservice.dk As we are determined to make a profit in 2020, we have considered various alternative ways of

Vestas secures 32 MW auction win in France

News release from Vestas MediterraneanMadrid, 30 June 2020 The renewable energy producer Elicio has placed a 32 MW order for the Le Haut Plateau wind project in France. The contract includes the supply and installation of nine V136-3.45 MW wind turbines delivered in 3.6 Power Optimised Mode, as well as an Active Output Management 5000 (AOM 5000) service agreement for at least the next 20 years. Peter Goderis, Director Engineering & Construction at Elicio France, said: “Wind energy has a significant growth potential in France and is at the heart of Elicio’s strategy to contribute

Vestas wins 36 MW repowering order with Vattenfall in the Netherlands

News release from Vestas Northern and Central EuropeHamburg, 30 June 2020 Vestas has received an order from Vattenfall Wind Development Netherlands B.V. for the Jaap Rodenburg II project in the Netherlands. The wind project will be installed in the Province Flevoland, near Almere and will feature ten V117-3.45 MW turbines with 91.5 m towers delivered in 3.6 MW Power Optimised Mode to maximise energy production in the site’s medium to high wind conditions, while meeting the local tip height requirements. This repowering project will replace the 10 V66 turbines and will more than double

Metso Corporation’s partial demerger has been registered

Neles Corporation, stock exchange release, June 30, 2020 at 20:00 EESTThe Boards of Directors of Metso Corporation (“Metso”) and Outotec Oyj have resolved to complete the combination of Metso’s Minerals business and Outotec Oyj through a partial demerger of Metso in accordance with the demerger plan and combination agreement signed on July 4, 2019. The completion of Metso’s partial demerger was registered today at the Finnish Trade Register. After the partial demerger, Metso became Neles Corporation (“Neles”). Trading in the shares of Neles on the official list of Nasdaq Helsinki Ltd

Metso Corporation’s partial demerger has been registered – Metso Corporation and Outotec Oyj have completed the combination of Metso’s Minerals business and Outotec

Metso Outotec Corporation stock exchange release on June 30, 2020 at  8:00 pm EEST The Boards of Directors of Metso Corporation (“Metso”) and Outotec Oyj (“Outotec”) have resolved to complete the combination of Metso’s Minerals business (the “Metso Minerals Business”) and Outotec through a partial demerger of Metso in accordance with the demerger plan and combination agreement signed on July 4, 2019. The completion of Metso’s partial demerger was registered today at the Finnish Trade Register. After absorbing the Metso Minerals Business, Outotec became Metso Outotec Corporation (“Metso

Sinch AB (publ): Change in number of shares and votes in Sinch AB (publ)

Stockholm, Sweden – Sinch AB (publ) – XSTO: SINCH The total number of shares and votes in Sinch AB (publ), reg. no. 556882-8908 (“Sinch”), has changed during the month of June consequent upon the directed issue of 1,052,631 new shares to certain Swedish and international institutional investors. Subsequent to the directed share issue, the total number of shares and votes in Sinch as of June 30, 2020, was 59,985,934. Through the directed share issue, Sinch’s share capital has increased with SEK 105,263.1, and, as of June 30, 2020, amounted to SEK 5,998,593.4. For further information,

Vestas secures 49 MW order in Italy for 2 MW and 4 MW platform turbines

News release from Vestas MediterraneanMadrid, 30 June 2020 Vestas has received a 49 MW order for two projects in Italy that showcase the versatility of Vestas’ product portfolio. The auction-based projects, located in the Campania region, will include six V110-2.0 MW wind turbines delivered in 2.2 MW Power Optimised Mode and ten V117-3.45 MW wind turbines in 3.6 MW operating mode. The supply and installation contract also includes a 5-year Active Output Management 5000 (AOM 5000) service agreement.  “This order showcases how our diverse portfolio continues to offer the winning

Ascelia Pharma completes a directed new share issue of 4,697,781 shares, raising approximately SEK 98.7 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA, NEW ZEALAND, HONG KONG, SINGAPORE OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE MAY BE UNLAWFUL, WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES Ascelia Pharma AB (publ) (ticker: ACE) (“Ascelia Pharma” or the “Company”) has, based on the authorisation granted by the annual general meeting on 6 May 2020, resolved on a directed new share issue to selected Swedish and international institutional

Scandion Oncology co-founders extend lock-up period

Scandion Oncology A/S (“Scandion Oncology”) announces that its two co-founders, CEO Nils Brünner and CSO Jan Stenvang, have extended the lock-up period for their Scandion Oncology shares with an additional three months (until October 1, 2020). In total, the lock-up agreements correspond to approximately 13 percent of the votes and capital in Scandion Oncology.CEO Nils Brünner and CSO Jan Stenvang have signed and prolonged the lock-up agreements for their shares with three months. The two co-founders commit to retain 90 percent of their holdings in the company until October 1, 2020. The

Leading Edge Materials to Participate in Graphite and Graphene Anode Research Project

Vancouver, BC, June 30, 2020 /CNW/ – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) announces the participation of its subsidiary Woxna Graphite AB in the newly launched research project “Graphite and graphene as battery electrodes” (the “Project”) which is part of the Vinnova funded competence centre Batteries Sweden (“BASE”). The Project will research the utilization of natural graphite for battery applications through determination of functionality of the natural graphite in batteries, the addition of

EQT sets target fund size for EQT Infrastructure V at EUR 12.5 billion

EQT has today set the target size for the EQT Infrastructure V fund at EUR 12.5 billion. The actual fund size is dependent on the outcome of the fundraising process and may ultimately be higher or lower than the target size. The EQT Infrastructure V fund’s investment strategy and commercial terms are expected to be materially in line with predecessor fund, EQT Infrastructure IV. To ensure continuity between two fund generations, EQT’s capital raisings usually follow a cycle with successor funds generally targeted to be in a position to commence investment activities when the predecessor

Changes in the number of shares and votes in Betsson AB (publ)

As at 18 June 2020, the total number of shares in Betsson AB (publ) (the “Company”) amounts to 288,986,476 shares, divided into: 31,822,000 class A shares; 245,009,460 class B shares and 12,155,016 class C shares. The total number of votes in the Company as at 18 June 2020 amounts to 575,384,476. At the Annual General Meeting held on 11 June 2020, one of the Company’s resolved resolutions was to carry out an automatic share redemption scheme by increasing the number of shares and votes in a share split (2:1). The number of shares and votes will be restored after the redemption is

Sweden’s vegan algae pioneer Simris to raise SEK 29 million through rights issue

Simris (FNSE: SIMRIS) is a pioneering agribusiness growing algae. Its purpose is to save and protect endangered marine habitats, by producing ingredients from farmed microalgae instead of fish and other marine animals. Following successful expansion to full industrial scale and first market milestones, the company is raising capital to support its launch on the US market. Last date of the subscription period is 8 July 2020.Simris is a multi-awarded innovation-based company and pioneers in the development of microalgae as a novel crop and biotechnological production platform. The purpose of

Change of number of shares and votes in Instalco

Pursuant to the Swedish Financial Instruments Trading Act (Sw. lagen (1991:980) om handel med finansiella instrument), Swedish companies whose shares are listed on a regulated market and who increases or reduces the total number of shares or votes in the company is to disclose such changes on the last trading day the same month.As of 30 June 2020, there are in total 50 474 022 shares and votes in Instalco AB (“Instalco” or the “Company”). The change in number of shares and votes in the Company is a result of the board of directors’ decision to issue in total 79 693 new shares within the

Oncopeptides announces leadership changes: Jakob Lindberg assumes a new role as CSO, and Marty J Duvall is appointed CEO

STOCKHOLM — June 30, 2020 — Oncopeptides AB (publ) (“Oncopeptides”) (Nasdaq Stockholm: ONCO) announces that the Board of Directors has appointed Marty J Duvall as Chief Executive Officer, CEO. Marty J Duvall replaces Jakob Lindberg who has been CEO since the restart of the company in 2011. Jakob Lindberg assumes the role as Chief Scientific Officer, CSO, replacing MD Christian Jacques who has held the position as CSO since 2018. Christian will continue as a Senior Advisor. .Marty J Duvall brings extensive global commercialization skills from executive leadership roles in pharma and

Change in the number of shares and votes in Scandic

The number of shares and votes in Scandic Hotels Group AB (publ) (“Scandic”) has changed in June 2020 as a result of the rights issue previously announced. The total number of shares in Scandic has in June 2020 increased by 86,907,312 shares, corresponding to 86,907,312 votes. Today, the last trading day of the month, the total number of shares and votes in Scandic amounted to 189,892,387.  The rights issue comprises a total of 88,272,918 shares, of which the remaining 1,365,606 shares will be registered at the Swedish Companies Registration Office in July 2020. For more

Board election in DNB ASA

The Annual General Meeting of DNB ASA was held on 30 June 2020. At the Annual General Meeting, Svein Richard Brandtzæg and Jens Petter Olsen were elected as new board members with a term of office of up to two years. Olaug Svarva was re-elected as Chair of the Board and Jaan Ivar Semlitsch was re-elected as a board member, both with a term of office of up to two years. The Board of Directors of DNB ASA now has the following members: Olaug Svarva (Chair of the Board) - 2022Svein Richard Brandtzæg (Vice Chair of the Board) - 2022Jens Petter Olsen - 2022Jaan Ivar Semlitsch - 2022

DNB ASA – Annual General Meeting held on 30 June 2020

DNB’s Annual General Meeting was held on 30 June 2020. The Annual General Meeting was held digitally as a result of the measures introduced due to the COVID-19 outbreak. All items on the agenda were adopted as proposed, cf. the notice published on 8 June 2020, including the following: The Annual General Meeting gave the Board of Directors authorisation to raise subordinated loans and other debt capital, cf. section 11-2 of the Financial Institutions Act, for a total value of up to NOK 20 billion, or the equivalent in foreign currency.  The minutes from the Annual General Meeting

Nyfosa has announced that the financing condition regarding SBB's sale of properties for SEK 4.9bn to Nyfosa has been resolved

As previously announced, on 10 June 2020, Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) signed an agreement for the sale of office properties totalling SEK 4.9bn to Nyfosa AB (“Nyfosa”). The transaction is conditional upon financing and approval from the Swedish Competition Authority (the “Competition Authority”). Nyfosa has today announced that they have acquired necessary bank loans, therefore the financing condition is resolved. A positive Competition Authority approval is expected during July. Closing is scheduled to take place as soon as possible after the Competition

Observe Medical ASA – Primary insider notice

Reference is made to the ongoing rights issue of 4,090,909 new shares (the "Offer Shares") at a subscription price of NOK 11.00 per share in Observe Medical ASA (the "Company") as announced in the Company's stock exchange announcement on 19 June 2020 (the "Rights Issue"). Primary insider, Kathrine Gamborg Andreassen, a member of the Company's board of directors, has today, on 30 June 2020, through her wholly-owned company Soleglad Invest AS, sold 144,428 subscription rights to subscribe for Offer Shares in the Rights Issue at a price of NOK 1.60 per subscription right. Following the

Number of shares and votes in Calliditas Therapeutics

During June, Calliditas Therapeutics AB (publ) has issued 9,230,770 common shares as a result of the initial public offering on The Nasdaq Global Select Market in the United States and concurrent private placement of common shares to certain qualified investors in Europe and certain other jurisdictions outside of the United States. Thus, as of June 30, 2020, the number of shares and votes in the Company amounts to 47,938,408. For further information, please contact: Renée Aguiar-Lucander, CEO at Calliditas Tel.: +46 722 52 10 06, email: renee.lucander@calliditas.com Mikael

Financing secured for Nyfosa’s acquisition of property portfolio for SEK 4.9 billion

As previously announced, Nyfosa signed an agreement on June 10, 2020 for the acquisition of a property portfolio comprising mainly tax-funded tenants at a value of SEK 4.9 billion from SBB i Norden AB.The transaction is conditional upon financing and the approval of the Swedish Competition Authority. Nyfosa’s financing has now been secured by raising new bank loans. A favorable ruling is anticipated from the Swedish Competition Authority, which is expected to be issued in July. Closing is scheduled to take place as soon as possible following approval by the competition authority and not

European Lingerie Group AB announces delay in delivery of annual report 2019

On 29 April 2020 European Lingerie Group AB (the "Company" and together with its subsidiaries from time to time, the “Group”) announced that it would not be able to deliver its annual audited financial statements for the year 2019 on or prior to 30 April 2020 as previously communicated in its reporting calendar due to uncertainty related to Covid-19 situation and its impact on the financial position of the Company. Furthermore, the Company announced, that it has ongoing discussions with certain holders of the Bonds and other investors to find solutions for the Group which are required to be

There are no items matching the current filter
There are no more items matching the current filter
Back to top